Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Semiconductor chipmaker Marvell Technologies Group Ltd. ( MRVL - Snapshot Report ) has been hit hard by an untoward decision announced by a federal jury, whereby the company has been ordered to pay a hefty amount of $1.17 billion as damages. The decision held Marvell guilty after the jury found the company infringing two patented technologies of Carnegie Mellon University. The technologies were being used by Marvell for making chips that are used in hard disk drives (HDDs).
Founded in 1900, Pittsburgh-based Carnegie Mellon University serves as a private research institute. The University conducts extensive researches in various areas starting from computing to the arts to the environment to biotechnology.
The patented technologies of CMU have helped Marvell to deliver high performing chips, which in turn would help HDDs to read data from high speed magnetic disks, accurately. According to the jurors, Marvell sold billions of chips incorporating the infringed technologies. They also mentioned that the damage amount could triple as Marvell’s infringing act was found to be willful.
During the trial, Marvell defended its case by stating that the company did not use the University’s patented technologies and that the patents were invalid. However, the company officials remained unavailable for comment after the verdict was announced. The case was filed before the U.S. District Court for the Western District of Pennsylvania in March 2009.
Following the news, Marvell shares plunged 10.3% in the day’s trade with another 2.97% fall in the after-hours. No doubt the shares will remain pressured till the final hearing scheduled in May 2013.
Marvell has been through tough times for the past few quarters. Macro-economic slowdown and a lackluster PC market are badly affecting its chip demand, resulting in weak revenue as well as earnings growth.
But Marvell maintained its share buyback and dividend payout to value shareholder loyalty. This is affecting both cash balance and cash from operations adversely.
Given the current situation, it seems obvious that such a huge damage amount will further jeopardize the chipmaker’s upcoming quarters.
We are also concerned about stiff competition from major semiconductor players, such as Intel Corp. ( INTC - Analyst Report ) , Texas Instruments Inc. ( TXN - Analyst Report ) and LSI Corp. ( LSI - Analyst Report ) .
Currently, Marvell Technology has a Zacks #4 Rank (Sell).
Read the full reports :
Analyst Report on LSI
Analyst Report on INTC
Analyst Report on TXN
Snapshot Report on MRVL